This site is intended for healthcare professionals only
LoginRegister
No Promotional Campaigns for GLP-1 Obesity Drugs: CDSCO Cautions Pharma FirmsNo Medicine Shortage: AIOCD Appeals to Chemists to Stay Alert and Serve as 'Jan Swasthya Rakshak'
Delhi HC Bars Dr Reddys from Selling Olymviq Over Similarity with Novo Nordisks OzempicDelhi HC Clears Mankind Prime Labs' CROSSRELIEF Trademark for Registration
Novartis to Acquire Excellergy in USD 2 Billion Deal to Boost Food Allergy PipelineCDSCO Panel Approves Novartis' Protocol Amendment proposal for Iptacopan Clinical study in Kidney...
Dr Reddys Labs reappoints G V Prasad as Co-Chairman, MDDr Reddy's Labs reappoints G V Prasad as Co-Chairman, MD
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 croreTPG to acquire 35% stake in SCHOTT Poonawalla from SII
Sun Pharma unit Taro recalls over 17k units of antifungal medication in USFDC recalls more than 60000 bottles of glaucoma medication in US
Dr Reddys Labs Switzerland incorporates new wholly-owned arm in VietnamDr Reddy's Labs Switzerland incorporates new wholly-owned arm in Vietnam
Govt Mulls Invoking Essential Commodities Act as Supply Disruptions Push API Costs Up to 300 pcPost-Patent Expiry Boom, Empagliflozin Sees Brand Flood, 147 Brands Launched: Pharmatrac
NPPA Fixes Retail Rates for 36 Key Drugs Like Atorvastatin, Dapagliflozin, GemcitabineNPPA fixes retail prices for Otsuka Pharmaceutical's 3 formulations
CDSCO Orders Strict Regulation of IVF, ART Medical Devices, Bars Unlicensed SaleCDSCO issues Revised Export NOC Guidance document for Manufacture of Unapproved, Approved New Drugs
Rick Suarez Named Head of AstraZenecas US Biopharma Business Amid USD 50 Billion Expansion PlanAstraZeneca Pharma India gets CDSCO approval for Enhertu for new breast cancer indication
Biocon Secures USFDA Nod for Generic Liraglutide Prefilled Pens for DiabetesBiocon posts more than twofold increase in Q4 profit
X